Current Cardiology Reports

• 

  Publication Venue For

  • Contemporary Medical Therapies for Patients with Peripheral Artery Disease and Concomitant Type 2 Diabetes Mellitus: a Review of Current Evidence..  24:567-576. 2022
  • Invasive Hemodynamic Evaluation of the Fontan Circulation: Current Day Practice and Limitations..  24:587-596. 2022
  • Contemporary Management of Abdominal Aortic Aneurysms..  24:431-438. 2022
  • Anesthetic Management in Adults with Congenital Heart Disease..  24:235-246. 2022
  • Burden and Impact of Arrhythmias in Repaired Tetralogy of Fallot..  24:225-234. 2022
  • Stroke Prevention in Patients with Patent Foramen Ovale..  23:183. 2021
  • Can Sound Public Health Policies Stem the Tide of Burgeoning Epidemic of Cardiovascular Disease in South Asians?.  23:181. 2021
  • Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19..  23:168. 2021
  • The Impact of Physical Activity on Pericarditis..  23:150. 2021
  • Chronic Thromboembolic Pulmonary Hypertension: the Bedside..  23:147. 2021
  • Chronic Thromboembolic Pulmonary Hypertension: the Bench..  23:141. 2021
  • Successful Peripheral Vascular Intervention in Patients with High-risk Comorbidities or Lesion Characteristics..  23:32. 2021
  • A Roadmap to Heart Regeneration Through Conserved Mechanisms in Zebrafish and Mammals..  23:29. 2021
  • The Current Evidence for Lipid Management in Patients with Lower Extremity Peripheral Artery Disease: What Is the Therapeutic Target?.  23:13. 2021
  • Approaching End-of-Life Decisions in Adults with Congenital Heart Disease..  22:173. 2020
  • Obesity Genomics and Metabolomics: a Nexus of Cardiometabolic Risk..  22:174. 2020
  • Intensive Care Unit Management of the Adult with Congenital Heart Disease..  22:136. 2020
  • Biventricular Conversion in the Borderline Hypoplastic Heart..  22:115. 2020
  • Pacing in Patients with Congenital Heart Disease: When Is It Helpful and When Is It Harmful?.  22:5. 2020
  • Management of Pulmonary Arterial Hypertension in the Pediatric Patient..  21:162. 2019
  • Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations..  21:161. 2019
  • Cath Lab Robotics: Paradigm Change in Interventional Cardiology?.  21:119. 2019
  • Valvular Disease in Marfan Syndrome: Surgical Considerations and Management..  21:23. 2019
  • Recent Advances in Congenital Heart Surgery: Alternative Perfusion Strategies for Infant Aortic Arch Repair..  21:13. 2019
  • Advances in Antiplatelet and Anticoagulant Therapies for NSTE-ACS..  21:3. 2019
  • Asymptomatic Severe Aortic Valve Stenosis-When to Intervene: a Review of the Literature, Current Trials, and Guidelines..  20:129. 2018
  • Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management..  20:130. 2018
  • Is There Still a Role for Digoxin in the Management of Atrial Fibrillation?.  20:105. 2018
  • Heart Transplantation and Mechanical Circulatory Support in Adults with Congenital Heart Disease..  20:81. 2018
  • Challenges in Aortic Valve Stenosis: Low-Flow States Diagnosis, Management, and a Review of the Current Literature..  19:130. 2017
  • Improving Medication Adherence in Coronary Heart Disease..  19:113. 2017
  • Pulmonic Valve Disease: Review of Pathology and Current Treatment Options..  19:108. 2017
  • Congenital and Acquired Valvular Heart Disease in Pregnancy..  19:96. 2017
  • Utilizing Hybrid Techniques to Maximize Clinical Outcomes in Congenital Heart Disease..  19:72. 2017
  • Coronary Artery Anomalies: When You Need to Worry..  19:39. 2017
  • Polymer-Free Drug-Coated Coronary Stents in Patients with Stable Coronary Artery Disease at High Bleeding Risk..  19:12. 2017
  • Functional Mitral Regurgitation: Appraising the Evidence Behind Recommended Treatment Strategies..  18:128. 2016
  • The Effect of Vigorous- Versus Moderate-Intensity Aerobic Exercise on Insulin Action..  18:117. 2016
  • Cardiovascular Complications of HIV in Endemic Countries..  18:113. 2016
  • A Bridge to Nowhere? Benefits and Risks for Periprocedural Anticoagulation in Atrial Fibrillation..  18:101. 2016
  • Rheumatic Heart Disease in the Twenty-First Century..  18:96. 2016
  • The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease..  18:81. 2016
  • Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline..  18:70. 2016
  • Coronary CT Angiography as a Diagnostic and Prognostic Tool: Perspective from a Multicenter Randomized Controlled Trial: PROMISE..  18:40. 2016
  • Antithrombotic Therapy After Peripheral Vascular Intervention..  18:26. 2016
  • Current State of Stem Cell Therapy for Ischemic Heart Disease..  18:17. 2016
  • Emotional triggering of cardiac dysfunction: the present and future..  17:91. 2015
  • Limb ischemia: cardiovascular diagnosis and management from head to toe..  17:611. 2015
  • Current status of percutaneous PFO closure..  16:477. 2014
  • Appropriateness of percutaneous coronary intervention: a review..  15:379. 2013
  • Transcatheter aortic valve replacement: an update..  15:367. 2013
  • Cigarette smoking and clopidogrel interaction..  15:361. 2013
  • Interventional treatment of hypertension: a new paradigm..  15:356. 2013
  • Approaches to decongestion in patients with acute decompensated heart failure..  15:335. 2013
  • Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis..  15:330. 2013
  • Radial versus femoral access for percutaneous coronary intervention: implications for vascular complications and bleeding..  14:502-509. 2012
  • Clopidogrel and PPI interaction: clinically relevant or not?.  14:49-58. 2012
  • Promise of factor Xa inhibition in atrial fibrillation..  14:70-78. 2012
  • The role of cardiac MR in new-onset heart failure..  13:185-193. 2011
  • Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go?.  12:315-320. 2010
  • Does myocardial perfusion imaging provide incremental prognostic information to left ventricular ejection fraction?.  12:155-161. 2010
  • In hypertension, the kidney breaks your heart..  10:470-476. 2008
  • Early intervention: which patients and how early?.  10:303-311. 2008
  • Late adverse events after drug-eluting stent implantation..  10:253-262. 2008
  • Lessons learned from the CRUSADE National Quality Improvement Initiative..  10:285-290. 2008